Paving the Way for Biomedical Innovation

The Frederick National Laboratory meets the nation’s most urgent biomedical research needs and serves as a national and global resource for the scientific community. 

2026 Technology Showcase highlights partnerships, debunks myths

2026 Technology Showcase highlighted a lot for the biotech community in just five hours.
Cancer Research

Prevention vaccines in clinical trials may help patients with rare, deadly childhood cancer syndrome

Scientists are studying whether using the same vaccine approach designed to prevent cancers associated with Lynch syndrome...

Biotech Connector presents immunotherapeutic strategies for an HIV functional cure

HIV/AIDS researchers presented at the August Biotech Connector about progress toward a functional cure for HIV.

Interdisciplinary team collaboration brings new TMA resource to researchers

Scientists developed and released the first publicly available tissue microarray panel for the NCI Patient-Derived Models...

Technology Showcase returns for its 9th year

Educational and networking opportunities for companies, investors, entrepreneurs, technology scouts and other biotech...

Uncommon testing capability supports CDC investigation into KSHV-infected organ transplants

Viral Oncology Section’s specialized testing capability supports CDC investigation into rise in Kaposi sarcoma disease in...

Team cuts one to two-year vaccine production timeline to fewer than 100 days

Vaccine Clinical Materials Program developed a new workflow to produce ready-for-testing vaccines in 13 weeks rather than the...
What is this?

Automated assay machine in the Cancer Genomics Research Laboratory. The lab investigates how genetic variation contributes to cancer susceptibility and disease outcomes. 

Information
Initiative

Scientific Standards Hub

Our scientists establish standards and reference reagents for diverse scientific  disciplines and  encourage the adoption of benchmarks  among researchers. 
8
disciplines with tools to help bridge gaps in scientific reproducibility.
Initiative

RAS Initiative

The RAS Initiative mobilizes the cancer research community to develop ways to treat cancers driven by the mutant RAS gene in an open model of collaboration among government, academic, and industry researchers.
220,000
People per year in the U.S. are diagnosed with cancers caused by KRAS mutations.
What is this? Surface representation of the structure of an oncogenic mutant of KRAS in complex with RAS-binding domains of RAF1 Kinase. The GMPPNP bound to oncogenic KRAS mutant is shown in ball-and-stick representation.
Information

Our Passion is Infectious

Shape Your Career

Work with the best of the best biomedical researchers and investigators. Be a part of groundbreaking solutions that benefit public health throughout the world. And, enjoy some of the best benefits in the region. We are looking for smart, passionate problem solvers for benchwork, data science, manufacturing, and more.